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Abstract
Background—Some human poxvirus infections can be acquired through zoonotic transmission. 
We report a previously unknown poxvirus infection in 2 patients, 1 of whom was 
immunocompromised; both patients had known equine contact.
Methods—The patients were interviewed and clinical information was abstracted from the 
patients’ medical files. Biopsies of the skin lesions were collected from both patients for 
histopathology, immunohistochemistry, and transmission electron microscopy analysis. Oral and 
skin swabs were collected from animals with frequent contact with the patients, and environmental 
sampling including rodent trapping was performed on the farm where the immunosuppressed 
patient was employed. “Pan-pox and high Guanine-cytosine” polymerase chain reaction assays 
were performed on patient, animal, and environmental isolates. Amplicon sequences of the viral 
DNA were used for agent identification and phylogenetic analysis.
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Results—Specimens from both human cases revealed a novel poxvirus. The agent shares 88% 
similarity to viruses in the Parapoxvirus genus and 78% to those in the Molluscipoxvirus genus 
but is sufficiently divergent to resist classification as either. All animal and environmental 
specimens were negative for poxvirus and both patients had complete resolution of lesions.
Conclusions—This report serves as a reminder that poxviruses should be considered in 
cutaneous human infections, especially in individuals with known barnyard exposures. The 
clinical course of the patients was similar to that of parapoxvirus infections, and the source of this 
virus is currently unknown but is presumed to be zoonotic. This report also demonstrates the 
importance of a comprehensive approach to diagnosis of human infections caused by previously 
unknown pathogens.
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Four genera of poxviruses contain species that infect humans: Orthopoxvirus, Parapoxvirus, 
Yatapoxvirus, and Molluscipoxvirus [1, 2]. Variola virus (the etiologic agent of smallpox) 
and molluscum contagiosum virus are primarily human pathogens, whereas the other 
poxviruses are zoonoses and humans are incidental hosts. The skin is the primary portal of 
entry for most poxviruses. These viruses are epitheliotropic and produce lesions that 
progress through well-described stages over several weeks [3]. Lesions may be restricted to 
specific body sites as in the case of parapoxvirus infections or generalized as seen in some 
orthopoxvirus infections such as smallpox and monkeypox.
Human infection with zoonotic poxviruses occurs as a result of direct or indirect contact (via 
fomites) with infected animals. Such infections are typically self-limiting but may be 
protracted and may involve varying treatment modalities in immunocompromised 
individuals, as demonstrated in this case report.
Case Reports
Patient 1
On 16 November 2012, a 17-year-old woman from eastern Tennessee developed an 
erythematous macule on her right cheek. She had an orthotopic heart transplant in 2007 and 
was maintained on tacrolimus and mycophenolate-mofetil. On 18 November the lesion on 
her cheek grew in size and a new macule emerged on her right temple. Over the next 1–2 
weeks, the lesions progressed from macules to papules to 1 to 1.5 cm brown nodules. The 
lesions were pruritic and painful. The patient had right cervical lymphadenopathy but no 
fever. On 20 November, the patient sought medical attention at a local children’s hospital, 
where she was referred to a dermatologist. The dermatologist excised the right temple lesion 
and submitted it for dermatopathologic evaluation. Histopathology revealed ballooning 
keratinocytes with eosinophilic cytoplasmic inclusions suggestive of a poxvirus infection. 
The dermatologist prescribed topical and oral acyclovir and oral minocycline.
On 29 November, the patient returned to her dermatologist for recurrence of the right temple 
lesion and development of 4 additional facial lesions, which followed the same progression 
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as the prior lesions. The dermatologist then referred her to a pediatric infectious disease 
specialist. The following day, at the consultation, 6 facial lesions at varying stages of 
progression were noted. The physician prescribed 5% imiquimod cream for thrice-weekly 
application and 2% mupirocin ointment for twice-daily application. The physician requested 
assistance from the Centers for Disease Control and Prevention (CDC) for laboratory 
confirmation of a suspected poxvirus infection. On 4 December, examination of the patient 
revealed progression of the lesion on the glabella and 3 new lesions on the chin. The crust 
overlying the oldest nodule on the cheek was separating from the underlying skin (Figure 
1A).
Despite the application of imiquimod for 2 weeks, the existing lesions progressed. On 13 
December, the patient returned to the dermatologist, who excised the larger nodules and 
removed the smaller lesions with cryotherapy. The dermatologist discontinued imiquimod to 
lessen the risk of scarring. Four months after excision, the patient had atrophic scars and 
underwent laser therapy to mitigate scarring. Fourteen months later, only minimal scarring 
was evident (Figure 1B).
The patient owned and cared for a horse, which was kept at a stable with other horses, a 
hinny, dogs, cats, and chickens. The patient had been working at this stable daily for 4 years 
and regularly handled hay, animal manure, and animal feed and collected chicken eggs. 
None of these animals had mucus membrane or skin lesions. This history of long-term 
exposure to a stable environment coupled with the initial pathology result of a poxvirus 
infection led to the suspicion that the patient was infected with a parapoxvirus. The patient 
reported no contact with small ruminants, cattle, rodents, or other wild animals. She had no 
recent travel or exposure to individuals with proliferative or vesicular skin lesions.
Patient 2
On 8 April 2013, an immunocompetent 28-year-old woman from western Missouri 
presented to her physician with a marble-sized nodule in the web space between the right 
index finger and thumb. She had right axillary lymphadenopathy but was afebrile. On 10–17 
March, the patient had traveled to northern Tanzania on a philanthropic mission providing 
care for donkeys and dogs. On 12 March, the patient sustained a rope burn on her right hand 
at the site of the lesion while restraining a donkey. On the following day, the patient rescued 
another donkey from an animal watering hole during which her hands were submerged in 
murky water. On 18 March, the patient returned to the United States and noticed a small 
papule at the site of the abrasion. By 30 March, the papule had developed into a nodule 
(Figure 1C). Given her travel history, she was referred to an infectious disease specialist and 
dermatologist. The dermatologist excised the lesion for dermatopathologic evaluation and 
the area was cauterized. Topical Neosporin cream as needed and 10 days of oral doxycycline 
and levofloxacin were prescribed for the patient. The day after the excision, the patient 
experienced painful swelling of her right arm consistent with cellulitis; all symptoms 
resolved after 4–5 days. As of May 1, three weeks after the excision, the patient reported 
resolution of the skin lesion (Figure 1D). Histopathology showed eosinophilic inclusions 
suggestive of poxvirus infection and surface bacterial colonization. The dermatologist 
requested CDC assistance for laboratory confirmation.
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While in Tanzania, the patient was primarily in contact with donkeys. The patient recalled 
seeing wounds on some of the donkeys’ withers and legs. The patient was part of a group of 
8 volunteers, and none of her colleagues developed lesions. In the United States, the patient 
owned dogs, cats, and a horse. The horse was kept in a nearby stable and the patient saw her 
horse 1 month prior to the trip. None of these animals had visible lesions.
METHODS
Clinical Specimens
One formalin-fixed, paraffin-embedded (FFPE) skin specimen from each patient was 
examined by histopathology, immunohistochemistry (IHC), transmission electron 
microscopy (TEM), and molecular assays.
Histopathology, Immunohistochemistry, and TEM
Sections, 3 micrometer in thickness, were cut from FFPE skin biopsy specimens and stained 
with hematoxylin and eosin. IHC for parapoxvirus was performed utilizing an 
immunoalkaline phosphatase technique. The antiparapoxvirus antibodies used were a 
polyclonal sheep anti–orf virus antibody and a polyclonal antibovine popular stomatitis virus 
antibody known to cross-react with orf. The FFPE sections from both patients were 
deparaffinized in xylene and embedded for thin-section TEM as previously described [4].
Polymerase Chain Reaction Assays
Extracted DNA was evaluated with the use of a pan-pox polymerase chain reaction (PCR) 
for general detection of poxvirus. The pan-pox PCR is a combination of 2 assays based on 
Guanine-cytosine (GC) content: a low-GC PCR for the detection of orthopoxvirus DNA, and 
a high-GC PCR for the specific detection of molluscipoxvirus and parapoxvirus DNA [5]. 
The amplicon sequences from the high-GC PCR assay were used for virus identification and 
phylogenetic analysis.
Animal and Environmental Sampling
On 26 December 2012, oral swabs were collected from 20 animals in contact with patient 1. 
The animals were inspected and no visible lesions consistent with poxvirus infections were 
present. In light of the second case, and because the both patients had contact with equines, a 
second extensive investigation was conducted in May 2013 at the farm where patient 1 
worked. The following occurred during the field investigation: (1) interviews of the farm 
owner and veterinarian were conducted to determine the origin, movements, and health 
history of animals on the property; (2) a thorough physical examination was conducted of all 
domestic animals present in the barn environment, and oral swabs and swabs of skin 
irregularities (scabs, scar, and wounds) were obtained from 12 animals; (3) swab specimens 
of fomites (animal stall walls, surfaces, bridles) with likely contact with the oral mucosa of 
the equines were obtained; and (4) 180 traps were set for rodents over 2 successive nights. 
For patient 2, oral swabs were collected in May 2013 from the patient’s 9 animals. Table 1 
lists the animal and environmental specimens collected. DNA was extracted from all swabs 
using the BioRobot EZ1 system DNA tissue kit (Qiagen) according to the modified 
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pretreatment protocol described previously, and specimens were tested using the pan-pox 
PCR assay [5].
RESULTS
Histopathology and Immunohistochemistry
The biopsies from both patients showed lesions typical of cutaneous poxvirus infection. The 
epidermis was acanthotic with a serocellular crust (Figure 2A). Keratinocyte ballooning 
degeneration and necrosis were prominent, and scattered, large, eosinophilic to amphophilic 
cytoplasmic inclusions were seen within the degenerating keratinocytes (Figure 2B). The 
dermis showed edema, capillary proliferation, and diffuse lymphocytic to mixed 
inflammatory infiltrates. Superficial colonization by bacteria was also noted. IHC 
demonstrated positive staining of keratinocyte cytoplasm using polyclonal sheep antisera 
generated against orf virus (Figure 2C). No staining was observed with the antisera 
generated against bovine popular stomatitis virus.
Transmission Electron Microscopy
The FFPE sections from both patients prepared for TEM revealed ovoid virions 
morphologically consistent with a poxvirus. Viral particles measured 200–300 nm by 100–
150 nm (Figure 3).
Molecular Assays and DNA Sequence Analysis
The low-GC PCR assay revealed no amplification, whereas results of the high-GC PCR 
assay confirmed a poxvirus infection in both patients; however, the patients’ isolates were 
negative for molluscipox and parapoxviruses using real-time PCR assays specific for these 
viruses. Phylogenetic analysis of the amplified sequences from both patients’ isolates 
indicated a novel, high-GC poxvirus (Figure 4). Results of a National Center for Bio-
technology Information Basic Local Alignment Search Tool search indicated the amplicon 
sequence had an 88% similarity to viruses in the Parapoxvirus genus and 78% to molluscum 
contagiosum virus within the Molluscipoxvirus genus. Notably, known zoonotic 
parapoxviruses (orf, pseudocowpox virus, and bovine popular stomatitis virus) share 92% 
similarity to each other along the same amplicon sequenced from both patients’ isolates. All 
98 specimens (from 29 animals and 25 environmental sites) were negative for poxvirus using 
the pan-pox PCR assay, and no rodents were trapped.
DISCUSSION
We present 2 cases of a cutaneous poxvirus infection involving a previously unknown, 
currently unclassified virus. The DNA sequence from the highly conserved viral RNA 
polymerase gene (J6R) suggests that this virus is most closely related to the Parapoxvirus 
genus but belongs to a unique clade that is distinct and divergent. IHC data demonstrate 
antigenic similarities between the new virus and the orf virus but not bovine popular 
stomatitis virus. Studies such as that of Housawi et al suggest a link between cross-reactivity 
and genetic relatedness among parapoxviruses [7]. In that study, the authors detected 
variations in the cross-reactivity of 27 monoclonal antibodies (mAbs) produced against orf 
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virus for different parapoxvirus species and strains [7]. Notably, the number of cross-reactive 
mAbs decreased when strains were more distantly related. Only 2 mAbs reacted with the 
squirrel poxvirus (SQPV_UKJ6R in Figure 4), whereas 6 mAbs reacted with the seal 
parapoxvirus (SELV_hiGC in Figure 4). Thus, our IHC result may suggest a closer 
relationship between the novel poxvirus and the orf virus than bovine popular stomatitis 
virus, but due to the paucity of studies on the cross-reactivity of parapoxviruses, no further 
deductions can be made about the similarities of this new virus to other known 
parapoxviruses.
Based on clinical presentation, it is reasonable to compare this novel virus with parapoxvirus 
infections. Parapoxviruses are widespread and infect a wide range of mammals including 
ungulates and seals, and human infection occurs as a result of direct or indirect (via fomites) 
contact with infected animals [8–10]. The viruses are hardy and highly resistant to 
environmental degradation under ambient conditions [11]. Patients with parapoxvirus 
infections typically have a well-defined history of animal contact such as slaughtering, meat 
processing, or bottle feeding [6, 10, 12]. We were unable to identify the origin of this new 
virus for either patient. Despite this, we cannot rule out a zoonotic source, as poxviruses 
have a wide host range and both patients had habitual exposure to the species-rich 
environment of a horse stable. The high degree of genetic similarity between the 2 viruses 
could suggest a common geographic origin; however, patient 2 also had contact with 
donkeys in Tanzania, and the timing of lesion origination suggests that she acquired the virus 
in Tanzania. Having failed to identify a potential source of fomite contamination originating 
in the United States (ie, equipment transported from Missouri to Tanzania), we are unable to 
resolve this conundrum.
The appearance and progression of our patients’ lesions was similar to those of the 
parapoxviruses. Persons infected with parapoxviruses generally present with solitary or 
regionally restricted lesions, usually on hands or arms rather than a disseminated rash, as is 
seen with some orthopoxvirus infections (smallpox, monkeypox). Furthermore, 
parapoxviruses replicate in regenerating epidermal keratinocytes; these cells are rich in 
nucleotide pools required for viral replication [13]. Both patients in this series had a 
compromised epidermal surface; patient 1 had mild acne and patient 2 sustained a rope burn 
at the site of the lesion 1 week prior to symptom onset.
These patients also highlight the differences in presentation between immunocompromised 
and immunocompetent persons. In immunocompetent patients, parapoxvirus lesions are 
generally self-limited, as was seen in patient 2. In contrast, immunocompromised patients 
often develop large, rapidly growing, exophytic lesions in atypical sites such as the face [14–
17], as observed in patient 1.
Treatment strategies for cutaneous poxvirus infections depend on the patient’s immune 
status and clinical course. In immunocompromised patients with orf virus lesions, 
application of imiquimod, an immunomodulatory agent, has been shown to result in the 
clearance of lesions within days to weeks [14–16], although in most of these cases, 
imiquimod was used in conjunction with other treatment modalities. Patient 1’s lesions 
appeared to be refractory to imiquimod therapy, as the lesions continued to grow despite its 
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application. Thus, the therapeutic effect of imiquimod in poxvirus infection remains unclear. 
Surgical excision and cryotherapy are also treatment options, which proved successful in 
both patients [17, 18]. Patient 2 experienced symptoms consistent with cellulitis, which is 
not uncommon in cutaneous infections.
Although we were unable to identify the source(s) of this novel poxvirus, we recommend the 
use of nonporous (rubber or latex) gloves for persons in contact with stable or barn 
environments, or involved in animal handling, particularly those individuals who are 
immunosuppressed or have open wounds on the hands. Also, all open wounds should be 
covered when handling animals, and skin should be immediately washed after contact with 
animals as poxviruses are known to infect damaged skin.
In summary, this is a report of a novel poxvirus infection in 2 patients with a common 
exposure to domestic animals, including equids. This report highlights the importance of a 
comprehensive approach to diagnosis. Collaboration between multiple specialists aided in 
dictating appropriate treatment modalities. In this instance, the identification of a novel 
poxvirus related to Parapoxvirus helped guide treatment options and possible outcomes.
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Figure 1. 
A, Large 1 to 1.5 cm facial nodules on patient 1 approximately 3 weeks after lesions 
developed. B, Patient 1’s lesions 14 months after excision and cryotherapy. C, Marble-sized 
lesion in the web space between the right index finger and the thumb of patient 2 about 3 
weeks after the lesion emerged. D, Patient 2’s lesion 3 weeks after excision and 
cauterization.
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Figure 2. 
A, Photomicrograph of the lesion from patient 2 shows acantholysis, keratinocyte ballooning 
degeneration, and dermal capillary proliferation. B, Cytoplasmic inclusions are seen within 
degenerating keratinocytes (arrowheads). C, Immunohistochemistry staining shows 
parapoxvirus antigens in red within the keratinocytes.
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Figure 3. 
A, Tissue from patient 1 with intracellular poxvirus particles. B, Mature (arrow) and 
immature (arrowhead) viral particles at higher magnification. Similar findings were seen in 
micrographs taken of tissue from patient 2 (C and D). L denotes lipids; T denotes 
tonofilaments.
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Figure 4. 
Phylogenetic tree showing the relationship of viruses isolated from patient 1 (2012_037) and 
patient 2 (2013_013) to other poxviruses. There was a single-nucleotide change between the 
patients’ isolates. The phylogenetic tree was constructed from 620 nucleotide sequences of a 
high-GC polymerase chain reaction amplicon targeting the highly conserved viral RNA 
polymerase gene. GenBank accession numbers of individual amplicons are listed: patient 1 
(KM491712), patient 2 (KM491713), 3 strains of bovine popular stomatitis virus (BPSV 
07005, GQ902054.1; BPSV_AR02, AY386265.1; BPSV 07058, GQ902053.1), 4 strains of 
orf virus (ORFV_NZ2p, AX754989; ORFV_NZ2, DQ184476.1; ORFV_IA82, 
AY386263.1;ORFV_SA00, AY386264), a red squirrel pox from the United Kingdom 
(SQRV_UKHE601899), a molluscum contagiosum–like virus from a donkey 
(MOCV_Donkey JQ269324), 3 pseudocowpox virus strains (PCPV 06025, GQ902049.1; 
PCPV 08024, GQ902050.1; PCPV 07012, GQ902051.1), a pseudocowpox-like virus from a 
US deer hunter (PCPV_Deer09001) [6], a sealpox virus (SELV_hiGC,), 3 strains of 
molluscum contagiosum virus (MOCV_T1, U60315.1; MOCV 08_031, GQ902057; MOCV 
09_029), and Nile crocodilepox virus (CROV_Nile, DQ356948.1). The DNA sequences 
were aligned with the use of the BioEdit and Clustal alignment programs. Phylogenetic 
analyses were performed with the use of the Bayesian analysis software packages BEAST 
and BEAUti, version 1.7.5. The analyses ran a Markov chain Monte Carlo chain length of 5 
000 000, with a Hasegawa–Kishino–Yano nucleotide substitution model, strict molecular 
clock, and sampling of every 1000 states. To root the dendrogram, a myxoma virus, 
MYXV_wel (JX565582) not shown, is used as the outgroup. The 0.02 scale bar denotes the 
genetic distance in substitutions per site.
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